Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work
06 Setembro 2023 - 5:05PM
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing
and precision medicine, today announced Great Place To Work® and
Fortune magazine have named Myriad Genetics to the 2023 Fortune
Best Workplaces in Health Care™ List.
The highly competitive list is based on the
analysis of survey responses from over 208,000 employees from Great
Place To Work Certified™ companies in the health care industry.
Earlier this year, Myriad achieved the certification, and 86%
of Myriad employees said the company is a great place to work
– 29 percentage points higher than a typical U.S. company.
“This Fortune Best Workplaces in Health Care
recognition is a testament to our commitment of inspiring a dynamic
and diverse culture, where career development is prioritized, and
all teammates have equal opportunity to grow and make a difference
in our patients’ lives,” said Shereen Solaiman, chief people
officer, Myriad Genetics. “We’re grateful for the passion, diverse
talents and enthusiasm our teammates bring to the global Myriad
workforce every day to help fulfill our mission of advancing the
health and well-being for all.”
Great Place To Work determines its lists using its
proprietary For All™ Methodology to evaluate and certify thousands
of organizations in America’s largest ongoing annual workforce
study, based on over 1.3 million survey responses and data from
companies representing more than 7.5 million employees this year
alone. Survey responses reflect a comprehensive picture of the
workplace experience.
For more information about careers at Myriad,
please
visit: https://myriad.com/working-at-myriad/joining-the-myriad-team/.
About Myriad GeneticsMyriad
Genetics is a leading genetic testing and precision medicine
company dedicated to advancing health and well-being for all.
Myriad develops and offers genetic tests that help assess the risk
of developing disease or disease progression and guide treatment
decisions across medical specialties where genetic insights can
significantly improve patient care and lower healthcare costs. For
more information, visit www.myriad.com.
About the Fortune
Best Workplaces in Health Care ListGreat Place To
Work selected the 2023 Fortune Best Workplaces in Health Care by
gathering and analyzing confidential survey responses from more
than 208,000 employees at Great Place To Work Certified
organizations in the health care industry. Company rankings are
derived from 60 employee experience questions within the Great
Place To Work Trust Index™ Survey. Great Place To Work determines
its lists using its proprietary For All™ Methodology to evaluate
and certify thousands of organizations in America’s largest ongoing
annual workforce study. This year alone, 1.3 million survey
responses were received and data from companies representing more
than 7.5 million employees. Read the full methodology.
About Great Place To Work®As the
global authority on workplace culture, Great Place To Work brings
30 years of groundbreaking research and data to help every place
become a great place to work for all. Its proprietary platform and
For All™ Model helps companies evaluate the experience of every
employee, with exemplary workplaces becoming Great Place To Work
Certified or receiving recognition on a coveted Best Workplaces™
List.
Follow Great Place To Work on LinkedIn, Twitter,
and Instagram or visit greatplacetowork.com and sign up for the
newsletter to learn more.
About FortuneThe Fortune mission
is to change the world by making business better. We achieve that
by providing trusted information, telling great stories, and
building world-class communities. We measure performance by
rigorous benchmarks. And we hold companies accountable. Our goal is
to make Fortune a force for good through its second century and
beyond. For more information, visit www.fortune.com.
Media Contact:Glenn Farrell(385)
318-3718PR@myriad.com |
Investor Contact:Matt Scalo(801)
584-3532IR@myriad.com |
Myriad Genetics (NASDAQ:MYGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Myriad Genetics (NASDAQ:MYGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024